The aim of this study was to investigate the effect of different cytidine-5Ј-diphosphocholine (CDP-choline) concentrations (0.1Ð1 mm) on acetylcholinesterase (AChE), (Na -ATPase activities were determined according to Ellman's method and Bowler's and Tirri's method, respectively. After an 1Ð3 h preincubation of the homogenised tissue with CDP-choline, a maximal AChE stimulation of about 25% for both adult and aged rats (p < 0.001) and a Na + ,K + -ATPase activation of about 50% for adult rats (p < 0.001) and about 60% for aged rats (p < 0.001) were observed, while hippocampal Mg 2+ -ATPase activity was not influenced in either adult or aged animals. It is suggested that: CDPcholine can restore hippocampal AChE and Na + ,K + -ATPase activities in the aged rat and thus it may play a role in improving memory performance which is impaired by aging and some neuronal disturbances.
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Introduction
CDP-choline is an essential intermediate in the biosynthetic pathway of the structural phospholipids of cell membranes, especially in that of phosphatidylcholine (PC) (Knapp and Wurtmann, 1999) . The enzyme choline phosphotransferase catalyzes the CDP-choline transformation to PC (Dorman et al., 1982) . The synthesis of CDP-choline is the limiting step in PC formation (Secades and Frontera, 1995) . CDP-choline also participates in the biosynthesis of sphingolipids and in particular in that of sphingomyelin (Secades and Frontera, 1995) , an important constituent of neuronal membranes. CDP-choline crosses the blood-brain barrier as cytidine and choline, which reach the brain and synthesize again CDP-choline in the cytoplasm (Secades and Frontera, 1995) . CDP-choline is incorporated widely in various brain areas (Romero et al., 1983) . CDP-choline, supplied exogenously, has beneficial physiological actions on cellular function that have been extensively studied and characterized in numerous model systems. CDP-choline and its hydrolysis products (cytidine and choline) play important roles in gen-0939Ð5075/2003/0300Ð0277 $ 06.00 " 2003 Verlag der Zeitschrift für Naturforschung, Tübingen · www.znaturforsch.com · D eration of phospholipids involved in membrane formation and repair. They also contribute to such critical metabolic functions as formation of nucleic acids, proteins and acetylcholine (ACh) (Secades and Frontera, 1995) . CDP-choline also affects the levels of various neurotransmitters (dopamine, serotonin and noradrenaline) (Martinet et al., 1979; Lopez et al., 1986; Petkov et al., 1990) . This substance was shown to increase noradrenaline levels in the cortex and hypothalamus (Petkov et al., 1990) . Moreover, it was shown to increase total urinary excretion of 3-methoxy-4-hydroxyphenylglucol, which reflects noradrenergic activity in rats and humans, suggesting that this compound increases noradrenaline release (Lopez et al., 1986) .
In animal models of brain aging, CDP-choline can improve learning and memory performance, probably by means of cholinergic action (Secades and Frontera, 1995) . Experiments showed that this substance, given in animal models of cerebral edema, restores Na + ,K + -ATPase activity, possibly through the formation of PC (Cohade et al., 1982) .
CDP-choline improves cognitive function in patients with Alzheimer's disease; this is due, in part, to the ability of the drug to stimulate the activity + ,K + -ATPase of serotoninergic, dopaminergic, and noradrenergic systems (Corona et al., 1983; Secades and Frontera, 1995) . Finally, this substance is effective as cotherapy for Parkinson's disease (Acosta et al., 1988) .
The aim of this study was to investigate the effect of different CDP-choline concentrations on the activity of three brain enzymes: (a) acetylcholinesterase (AChE, EC 3.1.1.7), the role of which is very important in ACh cycle and ACh release; (b) Na + ,K + -ATPase (EC 3.6.1.3), an enzyme implicated in neural excitability (Sastry and Phillis, 1977) , metabolic energy production (Mata et al., 1980) , uptake and release of catecholamines (Bogdanski et al., 1968) and Na + -dependent tryptophan uptake system (Herrero et al., 1983) ; and (c) Mg 2+ -ATPase, the role of which is to maintain high brain intracellular Mg 2+ concentrations, changes of which can control rates of protein synthesis and cell growth (Sanui and Rubin, 1982) . The effect of different CDP-choline concentrations on AChE and Na + ,K + -ATPase activities was studied in homogenates of adult and aged rat hippocampi.
Materials and Methods

Animals
Albino adult (4 months old) and aged (22 months old) Wistar rats of both sexes (Saint Savvas Hospital, Athens, Greece) were used in all experiments. Body weight was 200 ð 15 g (mean ð SD) for adult and 305 + 30 g for aged rats. The rats were housed four in a cage, at a constant room temperature (22∞ ð 1 ∞C) under a 12 h L:12 h D (light 08:00Ð20:00 h) cycle and acclimated 1 week before use. Food and water were provided ad lib. Animals were cared for in accordance with the principles of the Guide to the Care and Use of Experimental Animals.
Tissue preparation
Rats were sacrificed by decapitation. The hippocampus of individual adult (73 ð 11 mg) or aged rats (79 ð 11 mg) was rapidly removed, weighed and thoroughly washed with isotonic saline. Tissues from sixteen adult or aged animals were homogenized in 10 vol. ice-cold (0∞Ð4 ∞C) medium containing 50 mm Tris (hydroxymethyl)aminomethane-HCl (Tris-HCl), pH 7.4 and 300 mm sucrose using an ice-chilled glass homogenizing vessel at 900 rpm (4Ð5 strokes). Then, the homogenate was centrifuged at 1000 ¥ g for 10 min to remove nuclei and debris. In the resulting supernatant, the protein content was determined according to Lowry et al. (1951) and then the enzyme activities were measured. Three or four experiments were carried out using the same brain supernatant. The enzyme incubation mixture was kept at 37 ∞C.
Determination of enzyme activities
AChE activity was determined according to Ellman's method (1961) Bowler and Tirri (1974) . The enzyme reaction mixture and assay conditions of these enzyme activities were described in detail previously (Tsakiris, 2001 ).
Statistical analysis
Data were analyzed by two-tailed Student's ttest. P values of < 0.05 were considered statistically significant.
Results
The enzymatic activity measurements were carried out on homogenised adult and aged rat hippocampi. In the experiments in which enzyme preincubation with CDP-choline was needed, the determination of the activity was carried out in vitro after preincubation with 0.1, 0.5, 0.8 or 1 mm of CDP-choline at 37 ∞C. It has been estimated that the concentration of CDP-choline in rat plasma is approximately 1 mm, when a maximum dose of 30 mg per kg rat body weight is administered intravenously (Martinet et al., 1979 ). An estimate of the intracytoplasmic concentration of CDP-choline in rat brain (in vivo) has not been reported (Secades and Frontera, 1995) . The enzyme activities were investigated as a function of time of CDP-choline action on the enzyme activity and as a function of CDP-choline concentration.
Effect of CDP-choline on AChE activities
In the absence of CDP-choline, AChE activity in the homogenate of adult rat hippocampi remained at a steady level during the 3 h duration of the experiment. In the presence of this substance
(1 mm), the enzyme activity increased progressively reaching a maximum value of 20Ð25% (p < 0.01) after 1 h of CDP-choline action. Additionally, the effect of different concentrations of this compound on AChE activity was investigated in hippocampal homogenate of adult and aged rats. The results, illustrated in Fig. 1 , showed that 1 h of CDP-choline action on AChE in the hippocampus of adult rats resulted in a statistically significant stimulation of the enzyme activity by about 7% (p < 0.05) for a concentration of 0.1 mm, 17% (p < 0.01) for 0.5 mm and finally 23% (p < 0.001) for 0.8 mm and 1 mm. Fig. 1 also shows that 1 h of CDP-choline action on AChE in the hippocampus of aged rats resulted in a statistically significant stimulation of the enzyme activity by about 8% (p < 0.01) for a concentration of 0.1 mm, 18% (p < 0.001) for 0.5 mm and finally 25% (p < 0.001) for 0.8 mm and 1 mm. In each protocol, control and CDP-choline samples were tested simultaneously after an 1 h preincubation. In all cases, an 1 h preincubation of the homogenate with different concentrations of CDP-choline preceded the substrate addition. * p < 0.05; ** p < 0.01; *** p < 0.001 compared with control. campi remained at a steady level during the 3 h duration of the experiment. In the presence of this substance (1 mm), the enzyme activity increased progressively reaching a maximum value of about 45% (p < 0.001) after 1 h of CDP-choline action. Additionally, the effect of different concentrations of this compound on Na + ,K + -ATPase activity was investigated in hippocampal homogenate of adult and aged rats. The results, illustrated in Fig. 2 , showed that 1 h of CDP-choline action on Na + ,K + -ATPase of hippocampus of adult rats resulted in a stimulation of the enzyme activity by about 19% (p > 0.05) for a concentration of 0.1 mm, 35% (p < 0.01) for 0.5 mm, 45% (p < 0.001) for 0.8 mm and 50% (p < 0.001) for 1 mm. Fig. 2 also shows that 1 h of CDP-choline action on Na + ,K + -ATPase in the hippocampus of aged rats resulted in a statistically significant stimulation of the enzyme activity by about 21% (p < 0.05) for a concentration of 0.1 mm, 43% (p < 0.01) for 0.5 mm, 53% (p < 0.01) for 0.8 mm and finally 58% (p < 0.001) for 1 mm. Table I ised aged rat hippocampi. CDP-choline stimulated AChE by about 25% (p < 0.001) in aged hippocampus reaching partly the enzyme activity in adult hippocampus (difference of Ð 9%, p < 0.05). Moreover, this substance stimulated Na + ,K + -ATPase by about 60% (p < 0.001) in aged hippocampus, whereas it increased the enzyme activity in a higher value compared with that in adult hippocampus (difference of + 20%, p < 0.01). The enzyme activities were appeared decreased by aging by about 30% (p < 0.001) for AChE and 25% (p < 0.01) for Na
Effect of CDP-choline on Na
-ATPase activity was found to be 10.24 ð 1.02 µmol Pi/h ¥ mg of protein and 9.02 ð 0.88 µmol Pi/h ¥ mg of protein in homogenised hippocampus of adult and aged rats, respectively (Table I) . CDP-choline in the concentrations used in our experiments appeared unable to affect the enzyme activity (p > 0.05).
Discussion
In this study we observed that 30 min of CDPcholine action in homogenates of hippocampus was able to affect significantly the activity of AChE (about 100% of the maximal effect, p < 0.01) and that of Na + ,K + -ATPase (about 80% of the maximal effect, p < 0.001). In a previous study (Plataras et al., 2000) we found that 30 min of CDP-choline action in whole brain homogenates was able to affect significantly the activity of AChE (about 50% of the maximal effect, p < 0.01) but not that of Na + ,K + -ATPase. It seems that the action of CDP-choline is specific for the hippocampus, a fact that could explain many of its pharmacological effects.
High concentrations of CDP-choline (1 mm) stimulated aged hippocampal AChE by about 25% reaching partly the enzyme activity in adult hippocampus. The enzyme activity had been decreased by about 30% because of aging (see Table I ). Therefore, CDP-choline might improve inhibited AChE activities in some neuronal disturbances [e. g. Alzheimer (Bowen and Dawison, 1986) ]. In parallel, CDP-choline has been reported to increase ACh synthesis and/or release (Pinardi et al., 1994; Dixon et al., 1997) , which could improve learning and memory performance in neurological disturbances (Secades and Frontera, 1995) . This fact is supported by our results that show a faster effect of CDP-choline on AChE in the hippocampus, a major center of memory procedures (Kandel et al., 2000) .
Additionally, high concentrations of CDP-choline (1 mm) stimulated aged hippocampal Na + ,K + -ATPase by 60% and can overcome the enzyme activity compared with that in adult hippocampus. The enzyme activity had been inhibited by about 25% because of aging (see also Table I ). Therefore, this stimulating enzymatic effect of CDP-choline could improve neural excitability (Sastry and Phillis, 1977) , metabolic energy production (Mata et al., 1980) and influence the catecholaminergic (Bogdanski et al., 1968) and/or serotoninergic mechanisms (Herrero et al., 1983) in some neuronal disturbances of aging. On the other hand hippocampal Mg 2+ -ATPase activity was not affected either by rat aging or by CDP-choline (Table I ).
In conclusion, CDP-choline can stimulate AChE and Na + ,K + -ATPase in homogenates of adult and aged rat hippocampi. This stimulation is greater and more rapid than the stimulation observed in + ,K + -ATPase 281 whole brain homogenates. Since hippocampus is a major center for memory performance, we believe that the changes in enzyme activities observed in our experiments may in part explain the ameliorating effect of CDP-choline on memory performance especially in cases of old individuals (Secades and Frontera, 1995) . Our study supports the findings of previous works (Secades and Frontera,
